RLY-5836

· Relay Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RLY-5836, covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors [Phase 1]